Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial

<strong>Background<br></strong> In areas co-endemic for Plasmodium vivax and Plasmodium falciparum there is an increased risk of P vivax parasitaemia following P falciparum malaria. Radical cure is currently only recommended for patients presenting with P vivax malaria. Expanding t...

Full description

Bibliographic Details
Main Authors:	Thriemer, K, Degaga, TS, Christian, M, Alam, MS, Rajasekhar, M, Ley, B, Hossain, MS, Kibria, MG, Tego, TT, Abate, DT, Weston, S, Mnjala, H, Rumaseb, A, Satyagraha, AW, Sadhewa, A, Panggalo, LV, Ekawati, LL, Lee, G, Anose, RT, Kiros, FG, Simpson, JA, Karahalios, A, Woyessa, A, Baird, JK, Sutanto, I, Hailu, A, Price, RN
Format:	Journal article
Language:	English
Published:	Elsevier 2022

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial

Similar Items